期刊文献+

干扰Sirt2促进C2C12成肌细胞分化 被引量:4

Silencing of Sirt2 Promotes C2C12 Myoblast Differentiation
在线阅读 下载PDF
导出
摘要 Sirt2是组蛋白去乙酰化酶(HDAC III)家族成员之一,对细胞周期、自噬、脂肪细胞分化、神经细胞存活等生物学过程的调节发挥重要作用.目前,Sirt2在肌肉发育过程中的研究尚未见报道.本文通过构建Sirt2慢病毒干扰载体,侵染C2C12成肌细胞,并用细胞免疫荧光化学、real-time PCR和Western印迹方法,检测其对成肌分化标志基因及相关信号通路因子的影响.结果显示,干扰质粒shRNA-663处理C2C12细胞后,Sirt2 mRNA及蛋白质表达水平与对照相比显著下调(P<0.01);C2C12细胞分化第4 d,MyoD,MyoG,MyHC mRNA及蛋白质表达均显著增加(P<0.01);PI3K,AKT,FoxO1磷酸化水平明显升高.结果表明,Sirt2可通过PI3K/AKT/FOXO1信号通路来促进成肌细胞分化,是肌生成的一个潜在调节因子. Sirt2 is one of the members of histone deacetyltransferase (HDAC III) family, which plays a keyrole in the regulation of various cellular processes, including cell cycle, autophagy, neuroprotection, adiposedifferentiation. Now, the study of Sirt2 on muscle development has not been reported. The effect of Sirt2 onmuscle differentiation was investigated by constructing Sirt2 lentivirus vectors to treat C2C12 myoblast, and wealso used immunofluorescent staining, real-time PCR and Western blotting to evaluate related gene expressionlevels. The results showed that the expression levels of Sirt2 mRNA and protein in C2C12 myoblast treated bySift2 lentivirus plasmid were significantly lower than those of control group. At day 4 of C2C12 myoblastdifferentiation, the expression of MyoD, MyoG and MyHC mRNA and protein as well as the phosphorylation ofPI3K, AKT and FoxO1 were significantly increased. It was suggested that Sirt2 could promote myoblastdifferentiation via the PI3K/AKT/FOXO1 signal pathway and be a potential regulator of myogenesis.
出处 《中国生物化学与分子生物学报》 CAS CSCD 北大核心 2014年第7期714-720,共7页 Chinese Journal of Biochemistry and Molecular Biology
基金 国家自然科学基金(No.31272410) 西北农林科技大学"创新团队建设计划"(No.ZD2012007) 国家生猪产业体系(No.CARS-36-04B)项目~~
关键词 Sirt2 成肌分化 C2C12 干扰载体 irt2 myogenic differentiation C2C12 interference vector
  • 相关文献

参考文献24

  • 1Yun K, Wold B. Skeletal muscle determination and differentiation: story of a core regulatory network and its context [J]. Curr Opin Cell Biol, 1996,8 (6): 877-889.
  • 2Pownall ME, Custafsson M K, Emerson C P Jr. Myogenic regulatory factors and the specification of muscle progenitors in vertebrate embryos[J]. Ann Rev Cell Devel Biol, 2002, 18 (1) : 747 -783.
  • 3Charge S B, Rudnicki M A. Cellular and molecular regulation of muscle regeneration [J]. Physiol Rev, 2004, 84 (1) : 209-238.
  • 4Lassar AB, Skapek S X, Novitch B. Regulatory mechanisms that coordinate skeletal muscle differentiation and cell cycle withdrawa[J]. Curr Opin Cell Biol, 1994,6 (6): 788-794.
  • 5Sabourin LA, Rudnicki M A. The molecular regulation of myogenesis[J]. Clin Genet, 2000, 57 (1) : 16-25.
  • 6Weintraub H. The MyoD family and myogenesis , redundancy, networks, and thresholds [J]. Cell, 1993,75 (7): 1241-1244.
  • 7Wang F, Nguyen M, Qin F X, et al. SIRT2 deacetylates FOX03a in response to oxidative stress and caloric restriction [J]. Aging Cell, 2007 , 6 (4) : 505 -514.
  • 8Lamming D W, Latorre-Esteves M, Medvedik O, et al. HST2 mediates SIR2-independent life-span extension by calorie restriction [J]. Science, 2005, 309 (5742) : 1861-1864.
  • 9North B J, Marshall B L, Borra M T, et al. The human Sir2 ortholog, SIRT2, is an NAD + dependent tubulin deacetylase [J]. Mol Cell, 2003, 11 (2) : 437444.
  • 10Vaquero A, Scher M B, Lee D H, et al. SirT2 is a histone deacetylase with preference for histone H4 Lys 16 during mitosis [J]. Genes Dev, 2006, 20(10): 1256-1261.

二级参考文献38

  • 1Accili D, Arden KC. FoxOs at the crossroads of cellular metabolism, differentiation, and transformation. Cell, 2004, 117(4): 421-426.
  • 2Brunet A, Bonni A, Zigmond M J, et al. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell, 1999, 96(6): 857-868.
  • 3Van Der Heide LP, Hoekman MF, Smidt MP. The ins and outs of FoxO shuttling: mechanisms of FoxO translocation and transcriptional regulation. Biochem J, 2004, 380(Pt 2): 297-309.
  • 4Van Der Host A, Burgering BMT. Stressing the role of FoxO proteins in lifespan and disease. Nat Rev Mol Cell Biol, 2007, 8(6): 440- 450.
  • 5Pang W J, Yu TY, Bai L, et al. Tissue expression of porcine FoxO1 and its negative regulation during primary preadipocyte differentiation. Mo Biol Rep, 2009, 36(1):165-176.
  • 6Nakae J, Kitamura T, Kitamura Y, et al. The forkhead transcription factor Foxol regulates adipocyte differentiation. Dev Cell, 2003.4(1): 119-129.
  • 7Bois PRJ, Grosveld GC. FKHR (FOXOla) is required for myotube fusion of primary mouse myoblasts. EMBO J, 2003, 22(5): 1147-1157.
  • 8Hribal ML, Nakae J, Kitamura T, et al. Regulation of insulin-like growth factor-dependent myoblast differentiation by Foxo forkhead transcription factors. J Cell Biol, 2003, 162(4): 535-541.
  • 9Kamei Y, Miura S, Suzuki M, et al. Skeletal muscle FOXO1 (FKHR) transgenic mice have less skeletal, muscle mass, down-regulated type I (Slow Twitch/Red Muscle) fiber genes, and impaired glycemic control. JBiol Chem, 2004, 279(39): 41114-41123.
  • 10Sabourin LA, Rudnicki MA. The molecular regulation of myogenesis. Clin Genet, 2000, 57(1): 16-25.

共引文献12

同被引文献27

  • 1Mussai F, Eqan S, Hiqqinbotham-Jones J, et al. Arginine dependence of acute myeloid leukemia blast proliferation: a novel therapeutic target [J]. Blood, 2015, 125(15) :2386-2396.
  • 2Estey E, Dohner H, Acute myeloid leukaemia [J].Lancet, 2006, 368(9550) : 1894-1907.
  • 3Ferrara F. Conventional chemotherapy or hypomethylating agents for older patients with acute myeloid leukaemia? [J]. Hematol Oncol, 2014, 32(1):1-9.
  • 4Vyas P, Appelbaum FR, Craddock C. Allogeneic hematopoietic cell transplantation for acute myeloid leukemia [J].Biol Blood Marrow Transplant, 2015, 21(1):8-15.
  • 5Imai S, Armstrong CM, Kaeberlein M, et al. Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase [J]. Nature, 2000, 403(6771) :795-800.
  • 6Dryden SC, Nahhas FA, Nowak JE, et al. Role for human SIRT2 NAD-dependent deaeetylase activity in control of mitotic exit in the cell cycle [J]. Mol Cell Biol, 2003, 23(9):3173-3185.
  • 7Sunami Y, Araki M, Hironaka Y, et al. Inhibition of the NAD-dependent Protein deacetylase S1RT2 Induces granulocytic differentiation in human leukemia cells [J/CD]. PLoS One, 2013, 8(2) : e57633.
  • 8Kim HS, Vassilopoulos A, Wang RH, et al. SIRT2 maintains genome integrity and suppresses tumorigenesis through regulating APC/C activity [J]. Cancer Cell, 2011, 20(4): 487-499.
  • 9Li Z, Xie QR, Chen Z, et al. Regulation of SIRT2 levels for human non-small cell lung cancer therapy [J].Lung Cancer, 2013, 82(1) : 9-15.
  • 10Eo SH, Kim DW, Choi SY, et al. PEP-1-SIRT2 causes dedifFerentiation and COX-2 expression via the MAPK pathways in rabbit articular chondrocytes [J]. Exp Cell Res, 2015, 339(2):351-359.

引证文献4

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部